NCT06502964Phase 2Recruiting

Study of ALTO-101 in Patients With Schizophrenia

Study sponsor: Alto Neuroscience

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-02Estimated
Enrollment · participants82Estimated
Source updated2025-12-26Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Oct 2025. After: Feb 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview